% | $
Quotes you view appear here for quick access.

Allergan plc Message Board

angelofoca 634 posts  |  Last Activity: Mar 7, 2016 4:22 PM Member since: Dec 15, 1999
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • angelofoca angelofoca Mar 7, 2016 4:22 PM Flag

    I would hope that the Odidis would give IPCI a $500K loan at 10% rather than dilute this cheaply - the cheapest they sold shares on the ATM before has been at $3.20 US - 10% is a nice return and it would keep from diluting themselves too.

  • Reply to

    Here is WHY Gregori trashes IPCI

    by insideguyyy Dec 14, 2015 7:57 PM
    angelofoca angelofoca Dec 17, 2015 5:36 PM Flag

    Wow - you are totally clueless - every "hard core liberal" and I bet even gregory understands exactly what I said. I take part of the blame, for not speaking at your level. Try this : read it over and over and over - slowly, and see if the wit and wisdom in it soaks into your obtuse head.

  • Reply to

    Here is WHY Gregori trashes IPCI

    by insideguyyy Dec 14, 2015 7:57 PM
    angelofoca angelofoca Dec 17, 2015 1:49 PM Flag

    Samsa 1 says : anyone who would hold that type of misguided grudge for that many year is a sociopath. or I guess just a hard core liberal LOL

    WOW, talk about a sociopath, you just insulted at least half this board with your ASININE remark.

    I noticed that you're about the only one that gives gregory any credence here, must be comforting to talk to your own kind.

    sorry fisherman, I fully agree with you, but when you're out fishing and a gnat bites you, don't you swat it ???

  • Reply to

    A good reason

    by angelofoca Nov 17, 2015 11:18 AM
    angelofoca angelofoca Nov 18, 2015 9:13 PM Flag

    But can you give me a good reason as to why someone would - for years, and years - hang around a MB spewing the same bull over and over and over and over???

    I can only think of one good reason, and that is that he got FIRED by the Nigerian CEO.

    Oh my god... gregori got canned by a Nigerian goat herder because he got caught with one of the goat herder's GOATS - he swore up and down that his intentions towards the juvenile goat were honorable - but the nigerian goat herder couldn't get over the fact that you had chosen a BILLY GOAT.. and so he CANNED YOU ! ! !

    Cheer up gregori - heart breaks like that only hurt for about two or three years - so you're approaching the end of the morning period.

    ps - in 3 or 4 years, when IPCI hits 50 bucks a share, I'm going to get me one of those yellow Lamborghini - can't wait.

  • Reply to

    A good reason

    by angelofoca Nov 17, 2015 11:18 AM
    angelofoca angelofoca Nov 17, 2015 11:57 AM Flag

    Well I can't do it - I can't spread mis-information as the AHs on this board do - so in fairness you would have to bring the current share prices to parity for a proper comparison - so if you did a 1 for 6 reverse split on ELTP, the price would be 1.80 and shares outstanding would be ~ 115 million - so they would have to earn $115 Million - still ROFLMFAO

  • angelofoca by angelofoca Nov 17, 2015 11:18 AM Flag

    dig a little deeper says - If you have a good reason not to buy ELTP I am all ears.*
    How about this - For IPCI to earn $1.00 per share... it has to earn $24 million - easily do-able and SOON.
    For ELTP to earn $1.00 per share... READY FOR THIS??? it has to earn $685 Million - YEA - LOL - $685 MILLION

  • angelofoca by angelofoca Sep 19, 2015 2:03 PM Flag

    Looking at the yahoo stock chart - what I see is that 178K traded at $2.61 not $2.92 - the $2.92 was a trade at the very end of day for 1K share and it may have been someone who in error keyed in $2.92 rather than $2.62

  • Reply to

    Seroquel XR potential

    by angelofoca Sep 18, 2015 2:13 PM
    angelofoca angelofoca Sep 19, 2015 1:30 PM Flag

    Don't agree with that at all - I don't think percentage has anything at all to do with market potential - It all has to do with how far along the path to approval the drug is - preclinical gets you 5% to 8 % - successful phase 1 about 10% to 15% - phase 2 , about 15 to 25 % phase 3 = 25 to 35% - FDA approved = 35 to 50% and usually the lower the percentage the bigger the milestone payments. - IPCI would be handing over a ready for market drug with 180 days exclusivity... if they don't get 50% they should get a very hefty up front payment.

  • Reply to

    SEC Filling: SCHEDULE 14A

    by orfelioulises Sep 18, 2015 9:53 PM
    angelofoca angelofoca Sep 19, 2015 1:01 PM Flag

    If good news does emerge... then whoever bought those shares is in deep do-do - because he/she acted on inside information... and it would be relatively simple to find out who it is.

  • angelofoca angelofoca Sep 18, 2015 4:35 PM Flag

    If I recall right, they did receive $5 million up front, and Novartis bought a couple of million shares of stock

  • angelofoca by angelofoca Sep 18, 2015 2:13 PM Flag

    When Will the Generic Be Available?: Some or all forms of Seroquel XR may become available as generic quetiapine xr after November 2016, depending on FDA approval and patent expiration.

    I believe IPCI was first to file and has 180 day exclusivity on all 5 strenghts, and I believe this is the drug that they have partnered with TEVA.

    p.s. Seroquel XR is a $1.2 BILLION drug - 6 months exclusivity = $600 Million x 60% (40% discount over brand name) = $360 million x 25% market capture during 6 month exclusivity = $90 million x 50% (50/50 split with Teva - most likely) = $45 million divided by 25 million shares = $1.80 earnings per share for 6 months x 20 p/e (reasonable for growing concern) = $36.00 +/- 20% = ~ $28.80 to $43.20 fair value per share... just on Seroquel XR.

    Sentiment: Strong Buy

  • angelofoca angelofoca May 27, 2015 2:41 PM Flag

    Investing 101:
    Find a stock trading for ~ $8.00, which "should be a least $15.00 a share..." and BUY, BUY, BUY ! ! !

  • Reply to

    Rexista Timeline

    by wimuskyfisherman May 21, 2015 11:36 AM
    angelofoca angelofoca May 21, 2015 5:00 PM Flag

    No, time frame is 10 months for approval (or Denial -CR letter) but, unlike ANDAs, it's given a firm date for the response.

  • Reply to

    Q & A??

    by zoos7 Mar 9, 2015 3:27 PM
    angelofoca angelofoca Mar 9, 2015 4:17 PM Flag

    I believe the presentation was 23+ minutes, so there was a 6+ minute Q & A - but the presentation was ended there, so no input/output

  • yahoo replacing "a", "first letter in the alhabet" with #$%$

  • Reply to

    Novartis will buy them out !

    by threewayswitch Nov 6, 2014 2:54 PM
    angelofoca angelofoca Nov 18, 2014 5:05 PM Flag

    Weird - when I post, #$%$ll the #$%$" in my text get repl#$%$#$%$ed by " #$%$ " #$%$s you #$%$#$%$n see in the text below.

    If I t#$%$ke it into notep#$%$d #$%$nd do #$%$ se#$%$r#$%$h #$%$nd repl#$%$#$%$e, it then posts properly. Anyone else h#$%$ving th#$%$t problem???

    hum#$%$n tri#$%$ls - if it w#$%$s #$%$ given th#$%$t these tri#$%$ls would work in hum#$%$ns, the m#$%$rket #$%$#$%$p

    hum#$%$n tri#$%$ls - if it w##$%$ #$%$ given th#$%$t these tri#$%$ls would work in hum#$%$ns, the m#$%$rket #$%$#$%$p

  • Reply to

    Novartis will buy them out !

    by threewayswitch Nov 6, 2014 2:54 PM
    angelofoca angelofoca Nov 11, 2014 4:15 PM Flag

    No... RSV is worth approx $1 Billion a year - CGF166 is worth approx $5 Billion a year.

    Although I would say that RSV has about 5 times better chance of it working... so in that way... they're about of equal value right now

  • Reply to

    So here's the question:

    by redspinelpinktopaz Nov 9, 2014 10:50 AM
    angelofoca angelofoca Nov 11, 2014 3:51 PM Flag

    Phase 1 studies, which primarily test for safety, require that a single patient be tested and monitored for safety before they move on to patient # 2, and possible/probable increase in dosage - a very slow process for first few patients.

    However, Doug said that the very first dosage is enough to show efficacy if it works... that means that within appox 6 months, we may know if it works or not - my feeling is that... since Novartis will be first to know... they may well make an offer for $200M for the Atoh 1 technology alone and all it's patents - which is basically the amount of the milestone payments in aggregate, if it were to go to completion, that would save Novartis anywhere between $100M to $250M in royalty payments PER YEAR.

    I'm guessing Doug will turn it down - If they make an offer... it will be a dead giveaway that it works.

    Eventually it could easily bring in $5 Billion a year, @ 5% royalty that would be $250M a year pure profit in royalties - assuming 14M shares, that would/could be $17.85 per share in EARNINGS x 10 p/e = 178.50 per share... oh... minus $20K a year for a secretary to count the f#@en money!!! - IF IT WORKS

  • Pfizer Inc. (NYSEFE) has notified Pain Therapeutics, Inc. (NASDAQ: PTIE) that it has decided to discontinue its agreement to develop and commercialize REMOXY™ (oxycodone) Extended-Release Capsules CII, an investigational extended-release oral formulation of oxycodone. Pfizer will return all rights, including responsibility for regulatory activities, to Pain Therapeutics, Inc.

    Holy s**t - 20K shares of IPCI now makes you a millionaire in 4 to 5 years... maybe sooner.

    Fair buyout offer from Pfizer - $500 Million up front = 16.00 share + voucher good for $500 Million when/if Rexista gets FDA approval, + voucher good for $500 Million when/if Regabatin gets FDA approval - 1.5B total buyout to Pfizer - $48.00 share possible to present shareholders within 4 years.

    assumes 30M fully diluted shares

  • Reply to

    How many of ur friends(now ex)

    by badford59 Jun 24, 2014 2:52 PM
    angelofoca angelofoca Jun 24, 2014 3:24 PM Flag

    I got all my nieces, nephews, my daughter and grandson all in on it -

    They are all averaged in at around $3.60 - $3.70

    popular??? hell yea!!! they can't thank me enough.

    I hope you're short big time, and get your whole family to short it too a$$hole!!!

237.93+1.62(+0.69%)Aug 26 4:01 PMEDT